This information was published on 2026-09-14T11:45:03 for IP Right Filed Published.
| Field | Value |
| (210) | 2696232 |
| (220) |
14 Sep 2026
|
| (300) |
US, 12 Mar 2026, 99698638
|
| (511) (510) |
Class 5
Medicinal preparations for use in oncology; pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; radiopharmaceutical preparations for the treatment of cancer Class 42 Scientific research and development; Pharmaceutical research and development; Research and development of antibodies; Research and development of medicines; Research and development of new products; Research and development of conjugated antibodies; Research and development in the field of pharmaceuticals; Research and development of advanced learning technologies and teaching methods; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer |
| (540) | WE NUKE CANCER |
| (550) | Word |
| (730) |
Actinium Pharmaceuticals, Inc.
|
| (750) |
Dentons Australia Limited
|
Find out more about publications on the About page.